Norway vs Saudi Arabia: Treatment success rate for patients treated for MDR-TB
Norway
91.0%
in 2022
Saudi Arabia
93.0%
in 2022
Norway rank
21st
Saudi Arabia rank
20th
Treatment success rate for patients treated for MDR-TB over time
- Norway
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 91.0% in Norway, a difference of 2.0%.
The two have swapped places 5 times across 12 shared years of data; in 2007 it was Norway ahead.
Norway ranks 21st and Saudi Arabia ranks 20th of 163 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 65.0% | 38.0% | 27.0% | Norway |
| 2010s | 76.6% | 59.4% | 17.1% | Norway |
| 2020s | 86.0% | 81.0% | 5.0% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Norway or Saudi Arabia?
- Saudi Arabia, at 93.0% against 91.0% in Norway as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Norway and Saudi Arabia?
- 2.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Norway and Saudi Arabia?
- 12 years are reported by both, from 2007 to 2022.
- How do Norway and Saudi Arabia rank globally for treatment success rate for patients treated for mdr-tb?
- Norway ranks 21st and Saudi Arabia ranks 20th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.